<?xml version="1.0" encoding="UTF-8"?><abstracts-retrieval-response xmlns="http://www.elsevier.com/xml/svapi/abstract/dtd" xmlns:ait="http://www.elsevier.com/xml/ani/ait" xmlns:ce="http://www.elsevier.com/xml/ani/common" xmlns:cto="http://www.elsevier.com/xml/cto/dtd" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/" xmlns:xocs="http://www.elsevier.com/xml/xocs/dtd" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"><coredata><prism:url>http://api.elsevier.com/content/abstract/scopus_id/65549096370</prism:url><dc:identifier>SCOPUS_ID:65549096370</dc:identifier><eid>2-s2.0-65549096370</eid><pubmed-id>19199044</pubmed-id><prism:doi>10.1208/s12248-009-9081-8</prism:doi><dc:title>Poly(ethylene glycol)-modified proteins: Implications for poly(lactide-co-glycolide)-based microsphere delivery</dc:title><prism:aggregationType>Journal</prism:aggregationType><srctype>j</srctype><citedby-count>30</citedby-count><prism:publicationName>AAPS Journal</prism:publicationName><source-id>4000148019</source-id><prism:issn>15507416</prism:issn><prism:volume>11</prism:volume><prism:issueIdentifier>1</prism:issueIdentifier><prism:startingPage>88</prism:startingPage><prism:endingPage>98</prism:endingPage><prism:pageRange>88-98</prism:pageRange><prism:coverDate>2009-03-01</prism:coverDate><dc:creator><author auid="26536514400" seq="1"><ce:initials>S.S.</ce:initials><ce:indexed-name>Pai S.S.</ce:indexed-name><ce:surname>Pai</ce:surname><ce:given-name>Sheetal S</ce:given-name><preferred-name> <ce:initials>S.S.</ce:initials> <ce:indexed-name>Pai S.</ce:indexed-name> <ce:surname>Pai</ce:surname> <ce:given-name>Sheetal S.</ce:given-name> </preferred-name><author-url>http://api.elsevier.com/content/author/author_id/26536514400</author-url><affiliation href="http://api.elsevier.com/content/affiliation/affiliation_id/60027950" id="60027950"/></author></dc:creator><dc:description><abstract original="y" xml:lang="eng"><ce:para>The reduced injection frequency and more nearly constant serum concentrations afforded by sustained release devices have been exploited for the chronic delivery of several therapeutic peptides via poly(lactide-co-glycolide) (PLG) microspheres. The clinical success of these formulations has motivated the exploration of similar depot systems for chronic protein delivery; however, this application has not been fully realized in practice. Problems with the delivery of unmodified proteins in PLG depot systems include high initial "burst" release and irreversible adsorption of protein to the biodegradable polymer. Further, protein activity may be lost due to the damaging effects of protein-interface and protein-surface interactions that occur during both microsphere formation and release. Several techniques are discussed in this review that may improve the performance of PLG depot delivery systems for proteins. One promising approach is the covalent attachment of poly(ethylene glycol) (PEG) to the protein prior to encapsulation in the PLG microspheres. The combination of the extended circulation time of PEGylated proteins and the shielding and potential stabilizing effects of the attached PEG may lead to improved release kinetics from PLG microsphere system and more complete release of the active conjugate. Â© American Association of Pharmaceutical Scientists 2009.</ce:para></abstract></dc:description><link href="http://api.elsevier.com/content/abstract/scopus_id/65549096370" rel="self"/><link href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=65549096370&amp;origin=inward" rel="scopus"/><link href="http://api.elsevier.com/content/search/scopus?query=refeid%282-s2.0-65549096370%29" rel="cited-by"/></coredata><affiliation href="http://api.elsevier.com/content/affiliation/affiliation_id/60027950" id="60027950"><affilname>Carnegie Mellon University</affilname><affiliation-city>Pittsburgh</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><authors><author auid="26536514400" seq="1"><ce:initials>S.S.</ce:initials><ce:indexed-name>Pai S.S.</ce:indexed-name><ce:surname>Pai</ce:surname><ce:given-name>Sheetal S</ce:given-name><preferred-name> <ce:initials>S.S.</ce:initials> <ce:indexed-name>Pai S.</ce:indexed-name> <ce:surname>Pai</ce:surname> <ce:given-name>Sheetal S.</ce:given-name> </preferred-name><author-url>http://api.elsevier.com/content/author/author_id/26536514400</author-url><affiliation href="http://api.elsevier.com/content/affiliation/affiliation_id/60027950" id="60027950"/></author><author auid="7102789936" seq="2"><ce:initials>R.D.</ce:initials><ce:indexed-name>Tilton R.D.</ce:indexed-name><ce:surname>Tilton</ce:surname><ce:given-name>Robert D.</ce:given-name><preferred-name> <ce:initials>R.D.</ce:initials> <ce:indexed-name>Tilton R.</ce:indexed-name> <ce:surname>Tilton</ce:surname> <ce:given-name>Robert D.</ce:given-name> </preferred-name><author-url>http://api.elsevier.com/content/author/author_id/7102789936</author-url><affiliation href="http://api.elsevier.com/content/affiliation/affiliation_id/60027950" id="60027950"/><affiliation href="http://api.elsevier.com/content/affiliation/affiliation_id/60027950" id="60027950"/></author><author auid="7004245320" seq="3"><ce:initials>T.M.</ce:initials><ce:indexed-name>Przybycien T.M.</ce:indexed-name><ce:surname>Przybycien</ce:surname><ce:given-name>Todd M.</ce:given-name><preferred-name> <ce:initials>T.M.</ce:initials> <ce:indexed-name>Przybycien T.</ce:indexed-name> <ce:surname>Przybycien</ce:surname> <ce:given-name>Todd M.</ce:given-name> </preferred-name><author-url>http://api.elsevier.com/content/author/author_id/7004245320</author-url><affiliation href="http://api.elsevier.com/content/affiliation/affiliation_id/60027950" id="60027950"/><affiliation href="http://api.elsevier.com/content/affiliation/affiliation_id/60027950" id="60027950"/></author></authors></abstracts-retrieval-response>
